Print this page|
SUSTAINABLE INNOVATION & HEALTH DIVIDEND FUND Summary of Investment Portfolio as at September 30, 2023 |
||||
| Top Twenty-Five Holdings * | ||||
| Description |
% of Net Asset Value |
|||
| 1. | Sagard Healthcare Royalty Partners | 17.4% | ||
| 2. | Meta Platforms Inc. | 5.5% | ||
| 3. | Alphabet Inc. | 5.4% | ||
| 4. | UnitedHealth Group Inc. | 5.3% | ||
| 5. | Constellation Software Inc. | 5.2% | ||
| 6. | Eli Lilly & Company | 5.2% | ||
| 7. | Thermo Fisher Scientific Inc. | 5.1% | ||
| 8. | Apple Inc. | 5.1% | ||
| 9. | Microsoft Corporation | 5.1% | ||
| 10. | AbbVie Inc. | 5.1% | ||
| 11. | Advanced Micro Devices Inc. | 5.1% | ||
| 12. | AstraZeneca PLC | 5.0% | ||
| 13. | Merck & Co., Ltd. | 4.9% | ||
| 14. | Zoetis Inc. | 4.9% | ||
| 15. | DexCom, Inc. | 4.5% | ||
| 16. | Becton Dickinson & Co. | 3.9% | ||
| 17. | NVIDIA Corporation | 3.6% | ||
| 18. | Adobe Inc. | 3.5% | ||
| 19. | Blackstone Inc. | 3.0% | ||
| 20. | Tesla Inc. | 1.7% | ||
| 21. | Visa Inc. | 1.6% | ||
| "Top Twenty-Five Holdings" excludes any temporary cash investments * The Fund has only twenty one holdings. |
||||
| Asset Class | % of Net Asset Value |
|||
| Healthcare | 61.2% | |||
| Technology | 27.6% | |||
| Communication Services | 10.9% | |||
| Financials | 4.5% | |||
| Consumer Discretionary | 1.7% | |||
| Cash and Short-Term Investments | 9.5% | |||
| Other Assets (Liabilities) | -15.4% | |||
| 100.0% | ||||
| Total Net Asset Value | $29,472,987 | |||
| Total Assets | $34,266,690 | |||
| The Summary of Investment Portfolio may change due to ongoing portfolio transactions. Updates to this Summary of Investment Portfolio are posted to www.middlefield.com. | ||||